vs
Clipper Realty Inc.（CLPR）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
Clipper Realty Inc.的季度营收约是STANDARD BIOTOOLS INC.的1.9倍（$37.1M vs $19.6M），Clipper Realty Inc.净利率更高（-30.4% vs -177.4%，领先147.0%），Clipper Realty Inc.同比增速更快（-2.6% vs -11.5%），过去两年Clipper Realty Inc.的营收复合增速更高（1.8% vs -12.2%）
Clipper Realty Inc.旗下Clipper Equity由大卫·比斯特里瑟和山姆·莱文森牵头成立，在美国纽约与新泽西州拥有超60栋物业，合计数千套住宅单元。该企业最为人熟知的事迹是曾在2007年2月出价13亿美元收购纽约布鲁克林的斯塔雷特城住宅区，该交易曾是当时全球规模最大的房地产交易之一。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
CLPR vs LAB — 直观对比
营收规模更大
CLPR
是对方的1.9倍
$19.6M
营收增速更快
CLPR
高出8.9%
-11.5%
净利率更高
CLPR
高出147.0%
-177.4%
两年增速更快
CLPR
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $37.1M | $19.6M |
| 净利润 | $-11.3M | $-34.7M |
| 毛利率 | -5.2% | 48.5% |
| 营业利润率 | 21.8% | -168.5% |
| 净利率 | -30.4% | -177.4% |
| 营收同比 | -2.6% | -11.5% |
| 净利润同比 | -938.6% | -28.8% |
| 每股收益（稀释后） | — | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLPRLAB
| Q4 25 | $37.1M | — | ||
| Q3 25 | $37.7M | $19.6M | ||
| Q2 25 | $39.0M | $21.8M | ||
| Q1 25 | $39.4M | $40.8M | ||
| Q4 24 | $38.0M | — | ||
| Q3 24 | $37.6M | $22.1M | ||
| Q2 24 | $37.3M | $22.5M | ||
| Q1 24 | $35.8M | $45.5M |
净利润CLPRLAB
| Q4 25 | $-11.3M | — | ||
| Q3 25 | $-4.6M | $-34.7M | ||
| Q2 25 | $-1.4M | $-33.5M | ||
| Q1 25 | $-35.1M | $-26.0M | ||
| Q4 24 | $-1.1M | — | ||
| Q3 24 | $-1.1M | $-26.9M | ||
| Q2 24 | $-1.7M | $-45.7M | ||
| Q1 24 | $-2.7M | $-32.2M |
毛利率CLPRLAB
| Q4 25 | -5.2% | — | ||
| Q3 25 | 23.6% | 48.5% | ||
| Q2 25 | 27.8% | 48.8% | ||
| Q1 25 | -34.5% | 48.4% | ||
| Q4 24 | 28.8% | — | ||
| Q3 24 | 28.6% | 54.9% | ||
| Q2 24 | 26.8% | 46.1% | ||
| Q1 24 | 25.4% | 53.1% |
营业利润率CLPRLAB
| Q4 25 | 21.8% | — | ||
| Q3 25 | 23.6% | -168.5% | ||
| Q2 25 | 27.7% | -118.1% | ||
| Q1 25 | -59.9% | -80.8% | ||
| Q4 24 | 28.1% | — | ||
| Q3 24 | 28.6% | -120.9% | ||
| Q2 24 | 26.8% | -134.5% | ||
| Q1 24 | 25.4% | -132.2% |
净利率CLPRLAB
| Q4 25 | -30.4% | — | ||
| Q3 25 | -12.2% | -177.4% | ||
| Q2 25 | -3.5% | -153.7% | ||
| Q1 25 | -89.1% | -63.8% | ||
| Q4 24 | -2.9% | — | ||
| Q3 24 | -2.9% | -122.0% | ||
| Q2 24 | -4.7% | -203.3% | ||
| Q1 24 | -7.5% | -70.6% |
每股收益（稀释后）CLPRLAB
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.09 | ||
| Q2 25 | — | $-0.09 | ||
| Q1 25 | — | $-0.07 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.07 | ||
| Q2 24 | — | $-0.12 | ||
| Q1 24 | — | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $30.8M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-30.7M | $399.7M |
| 总资产 | $1.2B | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CLPRLAB
| Q4 25 | $30.8M | — | ||
| Q3 25 | $26.1M | $129.4M | ||
| Q2 25 | $32.0M | $158.6M | ||
| Q1 25 | $21.3M | $150.9M | ||
| Q4 24 | $19.9M | — | ||
| Q3 24 | $18.6M | $210.6M | ||
| Q2 24 | $20.3M | $269.8M | ||
| Q1 24 | $21.9M | $287.1M |
总债务CLPRLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | $55.2M | ||
| Q2 24 | $1.2B | $55.1M | ||
| Q1 24 | $1.2B | $55.0M |
股东权益CLPRLAB
| Q4 25 | $-30.7M | — | ||
| Q3 25 | $-25.0M | $399.7M | ||
| Q2 25 | $-21.9M | $424.5M | ||
| Q1 25 | $-20.1M | $454.6M | ||
| Q4 24 | $-5.4M | — | ||
| Q3 24 | $-3.6M | $489.3M | ||
| Q2 24 | $-1.8M | $510.3M | ||
| Q1 24 | $279.0K | $577.3M |
总资产CLPRLAB
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | $539.6M | ||
| Q2 25 | $1.2B | $557.0M | ||
| Q1 25 | $1.3B | $579.6M | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | $681.5M | ||
| Q2 24 | $1.3B | $708.7M | ||
| Q1 24 | $1.3B | $777.7M |
负债/权益比CLPRLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | 4396.73× | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $22.6M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-23.1M |
| 自由现金流率自由现金流/营收 | — | -118.1% |
| 资本支出强度资本支出/营收 | — | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势，按日历期对齐
经营现金流CLPRLAB
| Q4 25 | $22.6M | — | ||
| Q3 25 | $1.4M | $-22.2M | ||
| Q2 25 | $8.4M | $-20.7M | ||
| Q1 25 | $6.7M | $-30.3M | ||
| Q4 24 | $31.9M | — | ||
| Q3 24 | $6.3M | $-27.9M | ||
| Q2 24 | $8.8M | $-39.0M | ||
| Q1 24 | $6.3M | $-62.5M |
自由现金流CLPRLAB
| Q4 25 | — | — | ||
| Q3 25 | — | $-23.1M | ||
| Q2 25 | — | $-22.6M | ||
| Q1 25 | $-4.6M | $-35.3M | ||
| Q4 24 | $-37.9M | — | ||
| Q3 24 | — | $-30.1M | ||
| Q2 24 | — | $-41.0M | ||
| Q1 24 | $-14.7M | $-63.3M |
自由现金流率CLPRLAB
| Q4 25 | — | — | ||
| Q3 25 | — | -118.1% | ||
| Q2 25 | — | -103.6% | ||
| Q1 25 | -11.7% | -86.6% | ||
| Q4 24 | -99.5% | — | ||
| Q3 24 | — | -136.4% | ||
| Q2 24 | — | -182.2% | ||
| Q1 24 | -41.1% | -138.9% |
资本支出强度CLPRLAB
| Q4 25 | — | — | ||
| Q3 25 | — | 4.5% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | 28.6% | 12.4% | ||
| Q4 24 | 183.3% | — | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | 58.6% | 1.7% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLPR
| Residential Segment | $30.8M | 83% |
| Commercial Real Estate | $6.2M | 17% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
